ARCHIVES

Natcher: Multiple Year Funding Would Not be Approved If Presented As Request For Reprogramming

This article is from The Cancer Letter archive.

Vol. 11 No. 12 | March 22, 1985

Download PDF Visit The Full Archive

Related Articles

Nevins Reverses Position, Claims Potti Manipulated Data For Basis of Clinical Trials

February 17, 2012

NCI Director Halts STELLAR Trial, Seeks “Brilliant Ideas” For Breast Cancer Prevention.

March 2, 2007

House, Senate Reform Bills Move Closer To Floor Vote

August 12, 1994

Lilly Suspends Phase III Trial Of Tasisulam in Melanoma

January 28, 2011

Doxil/Caelyx Survival 3 Weeks Longer Than Topotecan

November 28, 2003

Piperacillin/Tazobactam Valuable Empiric Therapy For Febrile Neutropenia

October 31, 2003